Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Lishi Jiedu Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by the Nanjing Hospital of Integrated Traditional Chinese and Western Medicine. It is primarily investigated for its potential to prevent the recurrence of colorectal adenomas following surgical resection (polypectomy). The formula's name reflects its TCM therapeutic principles: "Jianpi" (strengthening the spleen), "Lishi" (draining dampness), and "Jiedu" (detoxifying). In the context of colorectal adenoma, it is hypothesized to modulate the intestinal microenvironment, reduce chronic mucosal inflammation, and inhibit the pathways leading to neoplastic recurrence. The efficacy and safety of the decoction are being evaluated in randomized, double-blind, placebo-controlled clinical trials.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianpi Lishi Jiedu Decoction.